Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
Stopped early
Conditions studied: Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma
In brief
This research trial studies cell-free deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in blood from patients with prostate cancer that does not respond to hormone therapy and has spread to other places in the body. Studying samples of blood from patients with prostate cancer may help doctors to learn more about the changes that occur in tumor cells over time and how they become resistant to anti-cancer drugs.
Key facts
- Study ID
- NCT02853097
- Run by
- University of Southern California
- People needed
- 7
- Starts
- 2016-06-14
- Expected to finish
- 2020-09-27
- Last updated by the study team
- 2021-04-05
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- A diagnosis of histologically confirmed prostate adenocarcinoma and falling into one of the following 5 groups:
- Currently receiving ADT (previously untreated for metastatic disease)
- These patients will be grouped into 3 cohorts: having received ADT for 3-6 months; for 1-2 years; and for > 3 years
- Scheduled to begin treatment with ADT (previously untreated for metastatic disease)
- Scheduled to begin treatment with enzalutamide (castration resistant / has received ADT / may have received abiraterone)
- Scheduled to begin treatment with abiraterone (castration resistant / has received ADT / may have received enzalutamide)
- Scheduled to begin treatment with docetaxel (castration resistant / has received ADT / has received enzalutamide and/or abiraterone)
- Have been diagnosed with either hormone-naive or castrate-resistant metastatic disease
- Ability and willingness to provide written and informed consent
You may not qualify if…
- Patients who receive combined ADT with docetaxel for hormone-naive metastatic prostate cancer
- Patients on intermittent ADT
Where it is running
- Los Angeles County-USC Medical Center — Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Keck Medical Center of USC Pasadena — Pasadena, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.